Nayzilam
Nayzilam (generic brivaracetam) — Mechanism of Action Brivaracetam is a selective synaptic vesicle protein‑2A (SV2A) ligand. Binding: It competes with endogenous SV2A sites, reducing calcium‑triggered vesicle release and thus decreasing neuronal excitability. Potency: 3–4× higher affinity for SV2A than levetiracetam, translating into a shorter dose interval and potentially a lower risk of dose‑related adverse effects. … Read more